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Prompt and Accurate Diagnosis, 




The concept of malaria elimination is to get rid of local transmission of malaria 
parasites in a defined geographical area. Among the measures required for malaria 
elimination is prompt and accurate diagnosis. Malaria diagnostic tools currently 
in use: clinical diagnosis, Malaria Rapid Diagnostic Tests (mRDT) and molecular 
diagnosis, have limitations. Clinical diagnosis can be used as first step in making 
prompt malaria diagnosis, but cannot confirm cases. Malaria RDTs satisfies the 
need for prompt diagnosis but has low accuracy in confirming cases. Accuracy of 
microscopy depends on making good blood films, and accurate film interpretation. 
Molecular diagnosis required for species-specific diagnosis of malaria parasites, 
and determination of genes that confers drug resistance to Plasmodium species is 
not available for routine use. As part of elimination efforts, there is development of 
mRDT kits that utilize urine or saliva instead of blood specimen, microscopy digital 
image recognition and different technologies for molecular diagnosis. So far, none 
of these diagnostic tools has satisfied the need for prompt and accurate diagnosis. It 
is therefore recommended that more than one diagnostic tool is needed for malaria 
elimination to be achieved in a given area. This will ensure early detection and 
 treatment of cases, as well as prevent the re-establishment of transmission.
Keywords: malaria, elimination, malaria diagnosis, clinical diagnosis, rapid 
diagnostic tests, microscopy, molecular diagnosis
1. Introduction
Malaria in humans is a parasitic disease caused by four species of Plasmodium: 
P. falciparum, P. vivax, P. ovale and P. malariae; with increasing recognition of 
enzoonotic transmission of a simian species, P. knowlesi. In most cases, the malaria 
parasites are transmitted through the bite of infected female anopheline mosqui-
toes. The mosquitoes carry infective sporozoites of malaria parasite in their salivary 
glands, and they inoculate or transfer these sporozoites into the blood stream of 
humans during blood meals [1]. After inoculation, the individual(s) is /are said to 
be infected with malaria parasites. The disease, malaria begins once (i) the asexual 
parasite multiplies within the red blood cells and (ii) the host produces some immu-
nological response against the parasites. On rare occasions, malaria parasite infec-
tion can be acquired by transfusion of blood from a malaria patient, also known 
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as transfusion malaria; transmission of infection to foetus in uterus through the 
placenta, also known as congenital malaria and by the use of contaminated syringes 
particularly among drug addicts [2].
Malaria results in a wide range of outcomes and pathologies with severity of the 
disease ranging from asymptomatic infection to rapidly progressive fatal illness. 
Generally, malaria is characterized by many signs and symptoms: fever, chills, 
headache, nausea, vomiting, sweating, chest or abdominal pain, diarrhea and 
cough. Severe infection may result in serious complications such as severe anemia, 
algid malaria, spleenomegaly, cerebral malaria, black water fever, hypoglycaemia, 
complications in pregnancy, respiratory distress, metabolic acidosis, pulmonary 
oedema, concomitant pneumonia, shock and coma [3]. Death due to malaria can 
occur as a result of delay in diagnosis and treatment of infected individuals. Thus 
malaria has remained a major threat to public health despite decades of control and 
elimination efforts.
2. Diagnosis of malaria
Prompt and accurate diagnosis is important in malaria elimination efforts. 
This will help in early detection of malaria cases before complications set in. Also, 
malaria cases are separated from other diseases that present with the same symp-
toms as malaria especially in cases of co-infections (with diseases such as typhoid 
fever, HIV, hepatitis, Covid-19 e. t. c.). Incorrect diagnosis of malaria will not only 
waste resources, but also delays treatment thereby resulting in poor outcome of 
patients. It may also contribute to increasing resistance of malaria parasite to avail-
able anti-malaria drugs, there by frustrating malaria elimination efforts. To achieve 
malaria elimination, different diagnostic tools are required. The malaria diagnostic 
tools could be broadly classified as provisional or clinical diagnosis and parasite-
based diagnosis. These diagnostic tools have been used over the years; nevertheless, 
they have their limitations.
3.  The use of clinical diagnosis or provisional diagnosis to achieve 
malaria elimination
Clinical diagnosis is achieved based on signs and symptoms presented by a 
patient. This is because the release of malaria antigens, pigments and toxins give 
rise to a cascade of pathological events. The earliest symptoms: headache, fever, 
body pains and chills could be used in making prompt diagnosis for malaria para-
site infection. [4] reported that 27.0% of mothers and caregivers practice home 
management of malaria because of the need for prompt diagnosis and treatment. 
The most commonly recognized and used symptom for clinical diagnosis is fever 
[5]. It has been used in making provisional diagnosis for malaria parasite infection 
in Nigeria and other malaria endemic regions. It gives prompt indication of malaria 
parasite infection in such area. A study in Nigeria reported 83.2% cases of malaria 
parasite infection among patients that presented with fever [6]. Another study in 
Southwestern Nigeria reported 66.8% cases of malaria parasite infection among 
febrile patients [7]. Even though these findings confirm that not all fever conditions 
can be attributed to malaria, but then a significant number of individuals would 
have been treated of malaria based on fever outcome. However, this may only be 
achievable in malaria endemic area because clinical diagnosis alone is not reliable 
and cannot be used to confirm malaria parasite infection. Its uncertainty and varied 
results makes it an inaccurate method for achieving malaria elimination. In malaria 
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endemic areas, under reporting of malaria cases (with inclusion of non-cases (false 
positive cases) and exclusion of actual cases (false negative cases)) using clinical 
diagnosis alone is most likely. A typical example can be presented by using the data 
in the work of [6]. In that study, 350 patients were examined for malaria parasite 
infection and 200 (57.14%) cases were confirmed using microscopy. However, 
clinical diagnosis showed 149 (42.57%) cases; 124 (35.43%) actual cases, 25 (7.14%) 
false positive cases and 76 (21.71%) missed cases or false negative cases. In the work 
of [8], clinical diagnosis recorded 74.30% prevalence of malaria as against 95.33% 
recorded with microscopy. This makes it clear that in malaria endemic areas, one 
can only use clinical diagnosis as a first step in making prompt or early malaria 
diagnosis and not to confirm malaria cases. In non-endemic areas, over reporting of 
cases may occur because diseases other than malaria may be the cause of common 
clinical signs observed in that area. Clinical diagnosis is therefore recommended for 
use alongside a parasite based diagnostic method.
3.1 Limitations of using clinical diagnosis in malaria elimination
There are issues in the use of clinical diagnosis alone to achieve malaria 
elimination.
a. Using clinical diagnosis alone, asymptomatic cases are unreported especially 
in P. vivax and P. ovale malaria where high parasitaemia is a prerequisite for 
mild and severe disease [9]. It is also applicable with P. malariae infection that 
is rarely fatal and the blood stage of the parasite persists for up to 40 years. In a 
study, [6] reported 37.8% malaria prevalence among non-febrile patients. This 
is to show that there might be missed cases of malaria parasite infection in a 
given population if one relies on clinical diagnosis alone.
b. There are inconsistencies in the choice of symptom for clinical diagnosis. While 
some people may focus on fever alone, some other may focus on chills, stomach 
upset, vomiting, body ache and headache [5]. This brings about uncertainty 
with this diagnostic tool.
c. The symptoms of malaria are non-specific. This makes precise calculation of 
malaria burden difficult especially in co-morbidity states. This may result in 
either under treatment of malaria cases or over treatment of malaria cases; 
none of which is good for malaria elimination. For example, [10] reported a 
case of Plasmodium vivax malaria and COVID-19 co-infection in Qatar. He 
presented the difficulty in distinguishing COVID-19 from malaria because 
COVID-19 presents with a variety of clinical manifestations including, but not 
limited to, fever, cough, diarrhea, vomiting, headache, myalgia and fatigue. 
This case was identified during the time of COVID-19 pandemic and it was 
possible that some other cases like this existed but more attention was given 
to COVID – 19 at the expense of other diseases including malaria. This is a 
typical scenario that could lead to missed cases of malaria, and malaria positive 
individuals still remaining in the environment serve as a source of infection 
and reinfection of other susceptible.
In the same way, malaria may be over reported and/or given more attention 
at the expense of other diseases in malaria endemic areas. In the work of [11], 
155 participants tested for malaria and typhoid fever infection shows there 
were 64 (41.7%) cases of malaria and 60 (38.0%) cases of typhoid fever, with 
40 (25.0%) cases that were mixed infection. If we look critically in that finding, 
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24 cases were malaria only whereas 20 cases were typhoid fever only. Then the 
total number of persons that would have been reported to have malaria based 
on clinical diagnosis alone is 84 (24 malaria only cases +20 typhoid fever only 
cases +40 cases of mixed infection). The implication will be excessive and indis-
criminate use of antimalarial. When such happens, some strains of malaria 
parasites with genes that confer resistance to commonly used antimalarial will 
emerge and bring about treatment failure. This will definitely frustrate malaria 
elimination efforts because researchers will need to go back to the laboratory 
to develop another antimalarial that can take care of the emergent strain of 
malaria parasite. Of course, the researchers will not be able to develop a new 
product without identifying and characterizing the malaria parasite strain, 
 using a parasite based diagnostic method.
4. The use of parasite-based diagnosis to achieve malaria elimination
Parasite based diagnosis is required to provide accurate result needed to achieve 
malaria elimination. The malaria case management guidelines released by WHO 
in 2009 recommended prompt parasitological confirmation of diagnosis either by 
microscopy or malaria rapid diagnostic test (RDT) in all patients with suspected 
malaria before treatment is administered [12]. The above statement supported the 
role of clinical or provisional diagnosis in making prompt and accurate diagnosis of 
malaria. Early indication of cases through clinical diagnosis (promptness) facilitates 
the use of parasite based diagnostic method (accuracy). On the other hand, malaria 
parasite infection has been reported among non-febrile individuals [6] and in line 
with making prompt diagnosis, frequent check-up or routine laboratory test using 
parasite based diagnostic method is required. This is to ensure that asymptomatic 
individuals are captured early enough before complications due to malaria set in. 
Parasite based diagnosis can also be achieved using molecular techniques.
5.  The use of malaria rapid diagnostic test (mRDT) to achieve  
malaria elimination
The World Health Organization recommends the use of mRDTs as a good 
alternative method for malaria diagnosis. As such, it has become a primary tool for 
parasitological diagnosis or confirmation of malaria. Malaria Rapid Diagnostic Tests 
(mRDT) are immuno-chromatographic tests that target certain proteins produced 
by Plasmodium species. There are different brands of mRDT kits. They include: 
SD Bio Line®, Tell®, First Response®, Sky Tech®, optiMAL®, Care Stat®, 
Paracheck®, Marrow Care®, Binaxnow® Malaria, Fyodor® and so on. They come 
in different test formats: strips, cassette etc., for ease of use and safety. These mRDT 
kits detect specific antigens (proteins) produced by malaria parasites in the blood 
of infected individuals. To achieve malaria elimination, the commercial test kits are 
manufactured with different antigens targeted to suit the local malaria epidemiol-
ogy of a given area [13]. Rapid Diagnostic Test (RDT) kits most widely used for 
malaria are based on the detection of the following target antigens of the parasite: 
Histidine-Rich Protein II (HRP2), Plasmodium Lactate Dehydrogenase (PLDH) and 
P-Aldolase [14]. Some of these antigens could be excreted in the urine or are found 
in the saliva of sick or infected individuals. Thus one may require any of blood, 
urine or saliva as specimen for conducting the test, depending on the mRDT brand 
in use. Nevertheless, blood has been the most widely used specimen because that is 
where the highest concentration of the malaria parasite antigens are found.
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Most commonly used RDT devices have two bands (a control line and a test 
line) and are designed to detect P. falciparum. The test line targets either histidine- 
rich protein-2 (HRP-2) or P. falciparum specific parasite lactate dehydrogenase 
(Pf-pLDH), depending on the RDT brand. However, RDTs that distinguish P. 
falciparum from the three non - P. falciparum species are available. Such RDT device 
may have either three bands (a control line and two test lines) or four bands (a con-
trol line and three test lines). In the case of RDT test device with three bands, one 
test line targets P. falciparum specific antigen; the second test line targets antigens 
common to the four species, such as pan-Plasmodium-specific parasite lactate dehy-
drogenase (pan-pLDH) or aldolase. In the case of RDT test device with four bands, 
the third test line targets Plasmodium vivax-specific parasite lactate dehydrogenase 
(Pv-pLDH).
In general, HRP2-based mRDTs are more sensitive and stable than mRDTs based 
on other Plasmodium antigens, and so are the mRDTs of choice in most endemic 
countries where P. falciparum malaria predominates [15]. Plasmodium lactate dehy-
drogenase (PLDH) which is another antigen detected by mRDT has been less widely 
used but have higher specificity, mostly due to a much shorter time to become 
negative [16]. Emphasis on the malaria antigen (HRP2) being stable when excreted 
in urine, may have encouraged [17] to experiment using urine specimen to conduct 
malaria rapid diagnostic test with mRDT kit manufactured to use blood specimen. 
In that study, they found that mRDT using urine specimen could serve as a practical 
method for detection of malaria parasites even though the sensitivity is dependent 
on the level of parasitaemia. It was based on this, that Fyodor®, a non-invasive 
dipstick test that uses monoclonal antibody to target P. falciparum protein (Highly 
repetitive cognate poly histidine-rich protein2 (HRP2) excreted in urine was devel-
oped. Fyodor® has been reported to demonstrate nearly equivalent performance 
compared to available blood-based RDT for the diagnosis of malaria [6, 18, 19]. 
Fyodor® was found to be useful in malaria diagnosis with 76.9% sensitivity and 
82.5% specificity, even when the parasitaemia level is as low as 260 parasites/μl of 
blood [6]. In addition to Fyodor®, [20] produced a prototype saliva-based RDT for 
P. falciparum gametocyte detection in carrier individuals. This is still in line with the 
efforts to advance malaria elimination strategies.
RDTs as diagnostic tools for malaria are simple to perform and provide quick 
result. It is a simple and fast way for health workers to test for malaria parasites in a 
patient’s blood. It is easy to learn and people living in rural areas can access and use 
this form of test because it does not require electricity or any other special equip-
ment. It is also simple to interpret the test result. Some (that require urine or saliva 
as specimens) are not invasive and so can be used closer to homes. Thus, it was 
developed for use in areas where the only realistic alternative is clinical diagnosis 
especially to tell if a feverish condition is caused by malaria parasite. This satisfies 
the need for prompt diagnosis in malaria elimination efforts. However, a major 
concern in the use of malaria RDTs is its low accuracy in reporting of malaria cases. 
In both malaria endemic and non-endemic areas, under reporting of malaria cases 
(with inclusion of non-cases (false positive cases) and exclusion of actual cases 
(false negative cases)) is likely. Using the same data in the work of [6], blood based 
mRDT reported 77 (22.0%) cases; 71 (20.29%) actual cases, 6 (1.71%) false positive 
cases and 129 (36.86%) missed cases or false negative cases. On the other hand, 
urine base mRDT reported 39 (11.14%) cases; 36 (10.29%) actual cases, 3 (0.86%) 
false positive cases and 164 (46.86%) missed cases or false negative cases. It could 
be deduced from the above that mRDT is more specific in reporting malaria cases 
than clinical diagnosis, even though its sensitivity seems low.
Using mRDT requires training of health workers on the importance of continu-
ous quality control monitoring for the mRDT kits while they use them [21, 22]. 
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The training should be carried out in connection with the brand of mRDT being used. 
The quality control can be achieved by checking its expiration date, storage conditions 
and using microscopy and/or PCR to assess the performance. In molecular epidemiol-
ogy studies to assess the performance of mRDTs, RDT used strips or cassettes can be 
used as a source of DNA for molecular detection of malaria parasites [23].
5.1 Limitations of mRDTs in malaria elimination effort
Many factors may affect the performance of malaria RDTs in achieving malaria 
elimination. These include:
a. Number of different species of malaria parasites infecting a host: Some RDTs 
can detect only one species (P. falciparum) while others detect multiple species 
(P. vivax, P. malariae and P. ovale) of malaria parasites. Even with mRDTs that 
detect multiple species of malaria parasites, the species are poorly classified as 
P. falciparum and non P. falciparum.
b. This test does not also detect actual parasite, rather it detects parasite antigens; 
this makes it difficult to accurately identify the species of malaria parasites 
present or prevalent in a given locality. The RDTs indirectly tells whether a 
patient has malaria parasites are present or absent. Also, RDTs cannot be used 
to quantify malaria parasites that are present in the blood.
c. Level of parasitaemia: High level of parasitaemia is normally required for 
recording high level of sensitivity with mRDTs. This has been shown with 
the significant weak positive correlation between malaria parasite density of 
microscopy result and mRDT results as reported by [6]. It then makes the test 
limit of detection for RDTs low; as a result, false negative results occur. In the 
work of [7], 32.8% false negative results were recorded. The implication is that 
if such RDT is used alone for malaria diagnosis, approximately 33 in every 100 
malaria cases will be missed and malaria elimination will be hard to achieve.
d. Variability in parasite antigenic structure: There is variability within the 
parasite antigen being detected by the mRDTs, which also leads to false nega-
tive results. While false-negative mRDT results have been attributed primarily 
to the tests’ limit of detection, [24, 25] have confirmed that genetic variation of 
P. falciparum can also affect mRDT performance. The variability may be due to 
the (i) presence or absence of the target epitope, (ii) variation in the number of 
epitopes present in a particular parasite isolate [26]. Genetic diversity among 
malaria parasites may be particularly important for PfHRP2-based RDTs, since 
the antigen consists of a number of alanine- and histidine - rich amino acid 
repeats [27] that vary in size among malaria parasite strains [28]. Comparison 
of the PfHRP2 sequences from several parasite strains has shown differences in 
the number of tri- and hexa- peptide repeat units and rare amino acid vari-
ants [27, 29, 30]. An additional report showed that the amino acid sequence of 
PfHRP2 in a Chinese isolate was different from that in South American (7G8) 
and Gambian (FCR3) isolates [31].
e. Persistence of the malaria antigens in the blood after treatment, thereby giving 
false positive results with mRDTs. False positive results occur because the 
mRDT devices can still detect the antigens of malaria parasites after the patient 
has been treated due to the persistence of HRP2 antigen in the blood for several 
days after infection. The device tests positive to infection when the patient is 
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actually free from the parasite infection. For instance, [7] reported 4.4% cases 
of false positive result with HRP2-based mRDTs. This limits their specificity 
and usefulness in accurate reporting of malaria cases.
f. Problem of storage. Even though RDTs are recommended for use in places 
electricity is poor or not available, it can be damaged by heat and humidity 
when not stored properly (in a cool dry place at a temperature of 2 °C to 8 °C). 
[32] reported that exposure to high temperature can damage the nitrocellulose 
membrane of the RDT test device or denature the antibodies in the test mem-
brane, thereby causing poor performance of RDTs in the tropics. The effect 
is mostly high level of false negative results which implies high number of 
unreported malaria cases.
6. The use of malaria microscopy to achieve malaria elimination
Malaria is commonly diagnosed using microscopy of stained blood films. 
Although the use of rapid diagnostics test for malaria diagnosis is on the increase, 
microscopy has remains the gold standard and as well serves as a reference standard 
in the evaluation of new tools for malaria diagnosis [33]. Venous blood or capillary 
blood can be used for malaria microscopy. This method involves the staining of 
thick and thin blood films on a clean grease free glass slide, to visualize the malaria 
parasite. Thick blood film is used for malaria parasite detection while the thin blood 
film is used for malaria parasite species identification. Commonly used stains for 
the preparation of blood films are Giemsa stain, Leishmann stain, Fields stains A 
and B. The standard procedure for preparation and examination of blood films for 
malaria parasite detection and species identification are contained in the documents 
by [33, 34]. A good binocular (compound or digital) microscope is required for 
accurate reading of the blood films.
In malaria endemic areas, routine microscopy is usually done using binocular 
light microscope. Microscopy is cheaper than the use of RDTs, considering the cost 
of consumables alone. Using microscopy, malaria parasite stages are seen and can 
also be counted. Microscopy has the advantage of providing a quantitative assess-
ment of peripheral blood parasitaemia and parasite stages as well as information 
on the other blood components [35]. Thus it gives accurate diagnosis of malaria 
when properly done. Due to its conventional use it helps to reduce cases of wrong 
administration of anti-malaria drugs to patients exhibiting non-malaria fever as 
a symptom. In Tanzania, this diagnostic method has help to reduce the wrong 
administration of malaria drugs to patients with non-malaria fevers [36].
The use of microscopy in malaria diagnosis will require continuous training, 
practice and experience. There is also need for assessment and supervision of 
microscopists (slide readers) for quality control of their test results. This is because 
detection, identification and quantification of malaria parasites using microscopy 
will depend on making good blood films, having a good microscope and accurate 
film interpretation by the laboratory scientist/technician. For improved microscopy 
needed to achieve malaria elimination, there is development of microscopy digital 
image recognition using artificial intelligence [37–43]. The concept is that a stan-
dard blood film is prepared using Giemsa stain or field stain. After that, a digital 
microscope or imaging scanner is used to capture the image viewed under the 
microscope. The captured image is stored in a computer and is used as an input for 
the image-recognition algorithms that will extracts useful visual features to locate, 
identify and count the malaria parasites. This is with the view to achieve better 
microscopy result because of inherent human factors in blood film preparation 
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and interpretation. When developed and certified, it will open new possibilities 
for automated recognition of malaria parasites in standard blood films and thus 
eliminate uncertainty about the quality of microscopic diagnoses worldwide.
6.1 Limitations of microscopy in malaria elimination
The challenges in the use of microscopy for malaria elimination are stated below:
a. Malaria microscopy requires specialized personnel for accurate detection and 
identification of malaria parasites. This is particularly important especially 
when the level of parasitaemia is low or in cases of mixed infection with differ-
ent Plasmodium species. It’s low sensitivity at low parasitaemia is a problem and 
can implicate the use of RDTs for false positive result.
b. Compared to mRDTs, this method is labour intensive and time consuming. 
Delay in its use may occur during blood film preparation or examination. In 
some cases, one may even have to prepare a new slide where poor staining or 
loss due to breaking of a slide occurs.
c. Variability in blood film preparation techniques and reading skills can account 
for inaccurate results. It may be due to slide differences because variation of 
parasite density within slides occurs even when prepared from a homogenous 
sample [44]. Accuracy of results obtained through microscopy also depends on 
individual technician performance in blood film preparation and examination, 
thereby making its standardization difficult.
d. Non accessibility of this method by rural areas due to lack of facilities is also a 
major issue. In malaria endemic countries where greater efforts are required for 
elimination, poor and high cost of electricity reduces the frequency of micros-
copy use for diagnosis. There could be a delay in providing results for patient 
especially when the blood films have to be made repeatedly.
e. Poor quality stains sold in the market can affect the quality of the thick and 
thin films, there by affecting the accuracy of the result.
f. The technology for automated microscopy using image-recognition algorithms 
has not been fully developed and certified. More so, the data base of the digital 
image to be analyzed is not yet robust to contain any distortion or unusual 
presentation of the malaria parasites in the blood films.
7. The use of molecular diagnosis to achieve malaria elimination
Molecular diagnosis of malaria is a laboratory techniques developed to detect 
and characterize the malaria parasites. It may not be used in routine diagnosis 
because of cost and time; but its use has increased the analytical sensitivity of 
assays for malaria parasites. In places where treatment failure occurs and drug resis-
tance is suspected, molecular diagnosis is required. It is needed for species specific 
diagnosis of malaria parasites, determination of genes that confers drug resistance 
to the Plasmodium species and in selecting treatment options. For instance, there 
is growing concern on the antigen variability expressed by P. falciparum the most 
prevalent malaria parasite species in the Sub-Saharan Africa that accounted for 
99.7% of estimated malaria cases in 2018 [45].
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Molecular diagnostic tool has the ability to detect low level parasitaemia and 
allows accurate identification of malaria parasite species. It is therefore a confirma-
tory test used for the diagnosis of malaria when microscopy shows negative result. 
Molecular diagnosis can also detect mixed infection [46] and identify asymptomatic 
malaria carriers who may be targeted for treatment [47]. With molecular diagnosis, 
large number of specimens can be processed simultaneously using standard pro-
tocols and equipment [48]. In the general protocol, DNA of Plasmodium species is 
extracted using DNA extraction kit from a given manufacturer. The extracted DNA is 
subjected to selective amplification of the target gene. This can be achieved by using 
more than 65 primer sets with at least five molecular targets that can be used to test as 
many as five human Plasmodium species: P. falciparum, P. ovale, P. malariae, P. vivax 
and P. knowlesi [49]. After the DNA amplification, electrophoresis is run and the 
bands interpreted in order to know the result of the test [50]. This basically explains 
Polymerase Chain Reaction (conventional PCR, nested PCR, real-time PCR) and 
Restriction Fragment Length Polymorphism (RFLP) as diagnostic tools for malaria. 
Polymerase Chain Reaction (PCR) was used to confirm parasitaemia using P. falci-
parum Merozoite Surface Protein 2 (MSP2) as a marker while Restriction Fragment 
Length Polymorphism (RFLP) was used to identify P. falciparum Sulfadoxine – 
Pyrimethamine (SP) resistance molecular markers at codons 51, 59, 108, 164 of 
dihydrofolate reductase (dhfr), and codons 437, 540, 581 and 431 of dihydropteorate 
synthetase (dhps) genes [51]. Nested-Polymerase Chain Reaction (nPCR) was used 
to detect P. falciparum DNA in blood and saliva of febrile patients in Cameroon [52].
Other molecular diagnostic techniques includes: Loop – Mediated Isothermal 
Amplification (LAMP), Flow Cytometry (FC) assay techniques, Nucleic Acid 
Sequence Based Amplification (NASBA), Luminex Xmax Technology and so on. 
These techniques can greatly improve detection, species-specific identification 
and precise parasite count by using species-specific primers or probes [49]. Loop-
Mediated Isothermal Amplification (LAMP) technique detected the conserved 18 s 
RNA gene of P. falciparum, P. vivax, P. ovale, P. malaria [46] and P. knowlesi [47]. 
Lamp has certain advantages compared to conventional PCR in the diagnosis of 
malaria because of its ability to perform the reaction and react without opening the 
tubes. It also has potential application for clinical diagnosis and surveillance of infec-
tious diseases without the need for sophisticated equipment and skilled personnel in 
developing countries. Flow cytometric technique was developed to detect and quan-
tify P. falciparum in the laboratories [53]. Flow cytometry was proposed as a malaria 
rapid diagnostic tool that counts the number of parasites and evaluate the malaria 
infected red blood cells [54]. FC is a very powerful tool in malaria research because 
it can use the nucleic acid content to identify various developmental stages of P. 
falciparum without being impaired by changes in the morphology of the parasite 
developmental stages [55]. Nucleic Acid Sequence Based Amplification (NASBA) is 
a homogenous, sensitive, isothermal and transcription based amplification system 
that uses three specific enzymes (Reverse transcriptase from avian myeloblastosis 
virus, T7 RNA polymerase and Ribonuclease H) [56]; and do not require expensive 
thermal-cycling equipment [57]. Prevalence and density of Plasmodium gametocytes 
has been determine using quantitative NASBA (QT-NASBA) that has the ability to 
detect as low as 0.02–0.1 gametocytes per microliter of blood [58]; it is also used 
increasingly to detect both P. falciparum and P. vivax gametocytes [59]. Luminex 
Xmax Technology approach is very useful for the diagnosis of parasitic diseases 
and it is based on bead flow cytometry assay. It has been used to detect all the blood 
stage of the four human Plasmodium species [60]. Luminex Technology can improve 
the speed, the accuracy and reliability of other PCR methods because it eliminates 
the need for gel electrophoresis, and samples can be handled simultaneously and 
continuously through 96-well plate format from DNA extraction [61].
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To enhance malaria elimination, molecular diagnosis should be used along-
side microscopy in the quality control (QC) of mRDTs. With proper storage and 
handling of mRDTs, the QC may have two foci in determining sensitivity and 
specificity of mRDTs: (i) the ability of the test devices to detect malaria parasite if 
present in a blood specimen. Here, different drops of blood from the same specimen 
are used to perform the two tests respectively. (ii) the ability of the test devices to 
detect malaria parasite if present in the same drop of blood collected from a speci-
men. Microscopy alone can be used to achieve item (i) and not item (ii), since the 
same drop of blood used for microscopy cannot be used for mRDT. One can pick 
a drop of blood for Microscopy and it contains malaria parasite and another drop 
picked for mRDT from the same specimen may not contain malaria parasite anti-
gen; and vice versa. Even, two slides prepared from the same blood specimen may 
not have the same microscopy readings. This is an issue relating to non-homogenous 
distribution of malaria parasites and the probability of picking malaria parasite 
in a drop of blood from a given blood specimen. Non-homogenous distribution of 
malaria parasites in the blood also affects PCR as much as microscopy and mRDTs. 
Nevertheless, PCR is a more robust tool for QC of mRDTs since it can achieve items 
(i) and (ii). To achieve item (ii), already used Rapid Diagnostic Test cassettes or 
strips are sources of DNA to detect malaria parasite by PCR [23]. Using the same 
cassette or strip, one can score the mRDT device based on what it picks from the 
specimen, rather than scoring it from another blood sample of the same specimen 
as is the case with microscopy. This approach is good for the overall quality control 
of mRDTs i. e. control for sensitivity, specificity, expiration, storage and handling.
7.1 Limitations in the use of molecular diagnosis for malaria elimination
a. Molecular diagnosis is still confined to few and special laboratories, thus it is 
not available for routine use.
b. PCR molecular assays are not feasible for field settings as it can be contami-
nated easily there by affecting the accuracy of the test result.
c. PCR also requires post amplification protocols like electrophoresis and it takes 
3–4 hours in order to know the result [50]. Even the real-time PCR (with 
reduced risk of contamination) developed to replace the conventional nested 
and semi-nested PCR is difficulty and time consuming [62]. In other words, 
it does not give prompt diagnosis.
8. Conclusion
A significant challenge in the global malaria elimination effort is inadequacy of 
the tools needed for prompt and accurate diagnosis. In asymptomatic condition, 
clinical diagnosis lacks both promptness and accuracy. In symptomatic condition, 
clinical diagnosis provides prompt indication of malaria but still lacks accuracy. 
Following routine or frequent check-up in asymptomatic condition, Microscopy 
and RDTs which are the most widely used parasite based diagnostic tools techniques 
provides more prompt and accurate result than clinical diagnosis. In symptomatic 
condition, Microscopy and RDTs provides accuracy to complement the promptness 
of clinical diagnosis. Between the two, RDT provides more prompt diagnosis than 
microscopy whereas microscopy provides more accurate result than RDT. Molecular 
diagnosis is not prompt, but has higher level of accuracy needed to detect, identify 
and characterize malaria parasite.
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No one diagnostic tool has satisfied the need for prompt and accurate diagnosis. 
For malaria elimination to be achieved, serious attention should be given to the per-
formances of the diagnostic tools. Where one tool fails, another one should be used 
to complement, rather than replace it. Clinical diagnosis is the basis for suspected 
malaria cases, even though routine check-up is highly encouraged. Confirmation 
of cases should be done using parasite based diagnostic tools. There is also need for 
scale up on the quality of parasite-based diagnostic methods in use. It is therefore 
recommended that more than one diagnostic tool is needed for malaria elimination 
to be achieved in a given area.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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